LY 206300
Alternative Names: LY 206301Latest Information Update: 22 Sep 1997
At a glance
- Originator Eli Lilly and Company
- Class Antihypertensives; Guanidines; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 22 Sep 1997 No-Development-Reported for Hypertension in USA (Unknown route)